{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:13Z","timestamp":1791996073873,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Tarsus Pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40123-024-01089-5","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T13:08:47Z","timestamp":1738069727000},"page":"555-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials"],"prefix":"10.1007","volume":"14","author":[{"given":"Elizabeth","family":"Yeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Paauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg J.","family":"Berdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Whitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Periman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair E.","family":"Boehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Bloomenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter O.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Koetting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Dhamdhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sesha","family":"Neervannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Ciolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"4","key":"1089_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/opo.12691","volume":"40","author":"AC Zhang","year":"2020","unstructured":"Zhang AC, Muntz A, Wang MTM, Craig JP, Downie LE. Ocular Demodex: a systematic review of the clinical literature. Ophthalmic Physiol Opt. 2020;40(4):389\u2013432. https:\/\/doi.org\/10.1111\/opo.12691.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1089_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/OPTH.S354692","volume":"16","author":"W Trattler","year":"2022","unstructured":"Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US Eye Care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153\u201364. https:\/\/doi.org\/10.2147\/OPTH.S354692.","journal-title":"Clin Ophthalmol"},{"issue":"15","key":"1089_CR3","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1038\/s41433-023-02500-4","volume":"37","author":"BD Ayres","year":"2023","unstructured":"Ayres BD, Donnenfeld E, Farid M, et al. Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH). Eye. 2023;37(15):3249\u20133255.","journal-title":"Eye"},{"issue":"6","key":"1089_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ajo.2010.11.024","volume":"151","author":"FG Holzchuh","year":"2011","unstructured":"Holzchuh FG, Hida RY, Moscovici BK, et al. Clinical treatment of ocular Demodex folliculorum by systemic ivermectin. Am J Ophthalmol. 2011;151(6):1030\u20134. https:\/\/doi.org\/10.1016\/j.ajo.2010.11.024.","journal-title":"Am J Ophthalmol"},{"key":"1089_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2147\/OPTH.S198585","volume":"13","author":"R Messaoud","year":"2019","unstructured":"Messaoud R, El Fekih L, Mahmoud A, et al. Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe. Clin Ophthalmol. 2019;13:1043\u201354. https:\/\/doi.org\/10.2147\/OPTH.S198585.","journal-title":"Clin Ophthalmol"},{"key":"1089_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/OPTO.S142708","volume":"10","author":"SR Fromstein","year":"2018","unstructured":"Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57\u201363. https:\/\/doi.org\/10.2147\/OPTO.S142708.","journal-title":"Clin Optom (Auckl)"},{"issue":"Suppl 1","key":"1089_CR7","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/ICO.0000000000001361","volume":"36 Suppl 1","author":"X Luo","year":"2017","unstructured":"Luo X, Li J, Chen C, Tseng S, Liang L. Ocular demodicosis as a potential cause of ocular surface inflammation. Cornea. 2017;36 Suppl 1(Suppl 1):S9\u201314. https:\/\/doi.org\/10.1097\/ICO.0000000000001361.","journal-title":"Cornea"},{"issue":"8","key":"1089_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/ICL.0000000000001003","volume":"49","author":"MK Rhee","year":"2023","unstructured":"Rhee MK, Yeu E, Barnett M, et al. Demodex blepharitis: a comprehensive review of the disease, current management, and emerging therapies. Eye Contact Lens. 2023;49(8):311\u20138. https:\/\/doi.org\/10.1097\/ICL.0000000000001003.","journal-title":"Eye Contact Lens"},{"key":"1089_CR9","doi-asserted-by":"publisher","unstructured":"Savla K, Le JT, Pucker AD. Tea tree oil for Demodex blepharitis. Cochrane Database Syst Rev. 2020;6(6):CD013333. https:\/\/doi.org\/10.1002\/14651858.CD013333.pub2.","DOI":"10.1002\/14651858.CD013333.pub2"},{"issue":"5","key":"1089_CR10","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1016\/j.ijid.2012.11.022","volume":"17","author":"DA Salem","year":"2013","unstructured":"Salem DA, El-Shazly A, Nabih N, El-Bayoumy Y, Saleh S. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis. 2013;17(5):e343\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2012.11.022.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"1089_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bjo.2010.201194","volume":"95","author":"PA Filho","year":"2011","unstructured":"Filho PA, Hazarbassanov RM, Grisolia AB, et al. The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp. Br J Ophthalmol. 2011;95(6):893\u20135. https:\/\/doi.org\/10.1136\/bjo.2010.201194.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1089_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.clae.2018.06.006","volume":"41","author":"K Frame","year":"2018","unstructured":"Frame K, Cheung IMY, Wang MTM, et al. Comparing the in vitro effects of MGO() Manuka honey and tea tree oil on ocular Demodex viability. Cont Lens Anterior Eye. 2018;41(6):527\u201330. https:\/\/doi.org\/10.1016\/j.clae.2018.06.006.","journal-title":"Cont Lens Anterior Eye"},{"key":"1089_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/OPTH.S399989","volume":"17","author":"M Farid","year":"2023","unstructured":"Farid M, Ayres BD, Donnenfeld E, et al. Delphi panel consensus regarding current clinical practice management options for Demodex blepharitis. Clin Ophthalmol. 2023;17:667\u2013679.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1089_CR14","doi-asserted-by":"publisher","first-page":"101492","DOI":"10.1016\/j.clae.2021.101492","volume":"45","author":"R Gonzalez-Salinas","year":"2022","unstructured":"Gonzalez-Salinas R, Karpecki P, Yeu E, et al. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to Demodex infestation: a randomized, controlled, double-masked clinical trial. Cont Lens Anterior Eye. 2022;45(4):101492.","journal-title":"Cont Lens Anterior Eye"},{"key":"1089_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3862684","author":"R Gonzalez-Salinas","year":"2021","unstructured":"Gonzalez-Salinas R, Yeu E, Holdbrook M, et al. Safety and efficacy of topical lotilaner ophthalmic solution 0.25% for the treatment of Demodex blepharitis: a pilot study. J Ophthalmol. 2021. https:\/\/doi.org\/10.1155\/2021\/3862684.","journal-title":"J Ophthalmol"},{"issue":"8","key":"1089_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1089\/jop.2021.0011","volume":"37","author":"R Gonzalez-Salinas","year":"2021","unstructured":"Gonzalez-Salinas R, Yeu E, Holdbrook M, et al. Collarette elimination and Demodex mite eradication with topical lotilaner ophthalmic solution, 0.25. J Ocul Pharmacol Ther. 2021;37(8):479\u201384. https:\/\/doi.org\/10.1089\/jop.2021.0011.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1089_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2022.2093755","author":"E Yeu","year":"2022","unstructured":"Yeu E, Holdbrook M, Baba SN, et al. Treatment of Demodex blepharitis: a prospective, randomized, controlled, double-masked clinical trial comparing topical lotilaner ophthalmic solution, 0.25% eyedrops to vehicle. Ocul Immunol Inflamm. 2022. https:\/\/doi.org\/10.1080\/09273948.2022.2093755.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"1089_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/ICO.0000000000003097","volume":"42","author":"E Yeu","year":"2023","unstructured":"Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M. Lotilaner ophthalmic solution, 025%, for the treatment of Demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (Saturn-1). Cornea. 2023;42(4):435.","journal-title":"Cornea"},{"issue":"10","key":"1089_CR19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ophtha.2023.05.030","volume":"130","author":"IB Gaddie","year":"2023","unstructured":"Gaddie IB, Donnenfeld ED, Karpecki P, et al. Lotilaner ophthalmic solution 0.25% for Demodex blepharitis: randomized, vehicle-controlled, multicenter, phase 3 trial (Saturn-2). Ophthalmology. 2023;130(10):1015\u20131023.","journal-title":"Ophthalmology"},{"issue":"3","key":"1089_CR20","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.clae.2024.102148","volume":"47","author":"S Muhammad Akhtar","year":"2024","unstructured":"Muhammad Akhtar S, Fareed A, Sohaib Asghar M, Mumtaz M, Kaur S. Efficacy and safety of lotilaner ophthalmic solution 02.5% for the treatment of Demodex blepharitis: a meta-analysis of randomized controlled trials. Cont Lens Anterior Eye. 2024;47(3):102148. https:\/\/doi.org\/10.1016\/j.clae.2024.102148.","journal-title":"Cont Lens Anterior Eye"},{"key":"1089_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2024.03.019","volume":"264","author":"M Talha","year":"2024","unstructured":"Talha M, Haris Ali M, Fatima E, et al. Efficacy and safety of lotilaner ophthalmic solution (0.25%) for the treatment of Demodex blepharitis: a GRADE assessed systematic review and meta-analysis of observational & experimental studies. Am J Ophthalmol. 2024;264:8\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2024.03.019.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1089_CR22","doi-asserted-by":"publisher","first-page":"e52664","DOI":"10.7759\/cureus.52664","volume":"16","author":"B Awan","year":"2024","unstructured":"Awan B, Elsaigh M, Tariq A, et al. A systematic review and meta-analysis of the safety and efficacy of 0.25% lotilaner ophthalmic solution in the treatment of Demodex blepharitis. Cureus. 2024;16(1):e52664. https:\/\/doi.org\/10.7759\/cureus.52664.","journal-title":"Cureus."},{"key":"1089_CR23","first-page":"361","volume":"65","author":"TO Coston","year":"1967","unstructured":"Coston TO. Demodex folliculorum blepharitis. Trans Am Ophthalmol Soc. 1967;65:361\u201392.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"1089_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/bjo.55.11.742","volume":"55","author":"FP English","year":"1971","unstructured":"English FP. Demodex folliculorum and oedema of the eyelash. Br J Ophthalmol. 1971;55(11):742\u20136. https:\/\/doi.org\/10.1136\/bjo.55.11.742.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1089_CR25","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1167\/iovs.05-0275","volume":"46","author":"Y-Y Gao","year":"2005","unstructured":"Gao Y-Y, Di Pascuale MA, Li W, et al. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005;46(9):3089\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1089_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1120672120937252","volume":"31","author":"S Jabbehdari","year":"2021","unstructured":"Jabbehdari S, Memar OM, Caughlin B, Djalilian AR. Update on the pathogenesis and management of ocular rosacea: an interdisciplinary review. Eur J Ophthalmol. 2021;31(1):22\u201333. https:\/\/doi.org\/10.1177\/1120672120937252.","journal-title":"Eur J Ophthalmol"},{"key":"1089_CR27","doi-asserted-by":"crossref","unstructured":"Sadri E, Paauw JD, Ciolino JB, et al. Long-term outcomes of 6-week treatment of lotilaner ophthalmic solution, 0.25% for Demodex blepharitis: A non-interventional extension study. Cornea. 2024. (in press).","DOI":"10.1097\/ICO.0000000000003484"},{"key":"1089_CR28","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.2147\/OPTH.S374530","volume":"16","author":"L O'Dell","year":"2022","unstructured":"O\u2019Dell L, Dierker DS, Devries DK, et al. Psychosocial impact of Demodex blepharitis. Clin Ophthalmol. 2022;16:2979\u201387. https:\/\/doi.org\/10.2147\/OPTH.S374530.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"1089_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/OPX.0000000000002111","volume":"101","author":"M Barnett","year":"2024","unstructured":"Barnett M, Simmons B, Vollmer P, et al. The impact of Demodex blepharitis on patient symptoms and daily life. Optom Vis Sci. 2024;101(3):151\u20136. https:\/\/doi.org\/10.1097\/OPX.0000000000002111.","journal-title":"Optom Vis Sci"},{"issue":"2","key":"1089_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5114\/aoms.2014.42585","volume":"10","author":"M Wesolowska","year":"2014","unstructured":"Wesolowska M, Knysz B, Reich A, et al. Prevalence of Demodex spp. in eyelash follicles in different populations. Arch Med Sci. 2014;10(2):319\u201324. https:\/\/doi.org\/10.5114\/aoms.2014.42585.","journal-title":"Arch Med Sci"},{"issue":"19","key":"1089_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015595","volume":"98","author":"S Cheng","year":"2019","unstructured":"Cheng S, Zhang M, Chen H, Fan W, Huang Y. The correlation between the microstructure of meibomian glands and ocular Demodex infestation: a retrospective case-control study in a Chinese population. Medicine. 2019;98(19): e15595.","journal-title":"Medicine"},{"issue":"4","key":"1089_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/0974-9233.142268","volume":"21","author":"V Bhandari","year":"2014","unstructured":"Bhandari V, Reddy JK. Blepharitis: always remember: Demodex. Middle East Afr J Ophthalmol. 2014;21(4):317\u201320.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"1089_CR33","first-page":"15","volume":"36","author":"RLB Siong","year":"2011","unstructured":"Siong RLB, Angelito B-dV, Ruben L-BS. Demodex sp. infestation in anterior blepharitis, meibomian-gland dysfunction, and mixed blepharitis. Philipp J Ophthalmol. 2011;36:15\u201322.","journal-title":"Philipp J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01089-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:45:40Z","timestamp":1739457940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01089-5","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Elizabeth Yeu had received consulting fees from, served on the board of directors of, and was an equity stakeholder in Tarsus Pharmaceuticals during the conduct of Saturn-1 and Saturn-2 trials and the planning and execution of this pooled analysis, before becoming an employee of Tarsus Pharmaceuticals. William E. Whitson is an equity stakeholder in Tarsus Pharmaceuticals. Marc R. Bloomenstein, Joseph B. Ciolino, Cecelia Koetting, Laura M. Periman, Patrick Vollmer, and Walter O. Whitley have received consulting fees from Tarsus Pharmaceuticals. Elizabeth Yeu, Kavita Dhamdhere and Sesha Neervannan are employees of Tarsus Pharmaceuticals. Joseph B. Ciolino, Jared D. Peterson, James D. Paauw, and Patrick Vollmer received research fees from Tarsus Pharmaceuticals or Ora Clinical Research. Blake Simmons, Gregg J. Berdy, John Meyer, and Blair E. Boehmer report no conflicts of interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The two studies analyzed in this post hoc analysis adhered to the tenets of the Declaration of Helsinki and were approved by the Institutional Review Board (IRB). All enrolled patients provided written informed consent using the IRB-approved informed consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}